Medtronic completes acquisition of Mazor Robotics

Medtronic plc announced it has completed the acquisition of the Israel-based company Mazor Robotics. Mazor shareholders will receive $58.50 per American Depository Share, or $29.25 per ordinary share, in cash. The total value of the acquisition is reported at $1.7 billion and ranks among the largest orthopedic deals completed in 2018, according to a company press release.

“With today’s announcement, in bringing the two companies together Medtronic aims to accelerate the advancement and adoption of robotic-assisted surgery in spine for the benefit of patients, providers and the health care system more broadly,” Geoff Martha, executive vice president and president of the restorative therapies group at Medtronic, said in the release. “This is the latest example of our surgical synergy strategy, which we believe will transform spine care through procedural solutions that integrate implants, biologics and enabling technologies like navigation, 3-D imaging, robotics and powered surgical tools.”

The Mazor X Stealth Edition, a co-development effort between Mazor and Medtronic, was recently cleared by the FDA. This system incorporates StealthStation software into the Mazor X robotic-assisted surgery platform, delivering procedural predictability and flexibility through real-time image guidance, visualization and navigation informed by interactive 3-D planning and information systems, according to the release.

Reference: